# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-206364
Filing Date
2026-05-05
Accepted
2026-05-05 16:06:12
Documents
57
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cytk-20260331.htm iXBRL | 10-Q | 2329131
2 | EX-31.1 | cytk-ex31_1.htm | EX-31.1 | 17363
3 | EX-31.2 | cytk-ex31_2.htm | EX-31.2 | 17395
4 | EX-32.1 | cytk-ex32_1.htm | EX-32.1 | 10804
| Complete submission text file | 0001193125-26-206364.txt |  | 8733359

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | cytk-20260331.xsd | EX-101.SCH | 1595517
61 | EXTRACTED XBRL INSTANCE DOCUMENT | cytk-20260331_htm.xml | XML | 1264575

Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50633 | Film No.: 26943003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)